Get ready before quantum computers can open today's locks.

Every pharma company locks its data with encryption. A powerful quantum computer will be able to pick the two lock designs almost everyone uses today — and attackers are already copying locked data to open later. Quantum-Ready GxP helps small and mid-size pharma companies find every one of those locks in their validated systems, judge what is at risk, and plan the replacement — calmly, before deadlines force it.

Free report: “Your 2035 Problem”

Your 2035 Problem: Quantum Risk in Validated Systems — the plain-English briefing on the post-quantum deadline, the Part 11 problem, and the revalidation trap. Written for QA and validation leaders.

Enter your email and the report download starts right away. We store your address to send occasional PQC-readiness notes for pharma QA leaders. No spam, no list resale; unsubscribe any time.

The problem, in plain English

Start with locks

Encryption is a lock on company data. When a scientist signs a batch record electronically, when a lab system stores trial results — a mathematical lock scrambles the data so only the right key can read it, or prove it has not been changed. Today's two common lock designs are called RSA and ECC.

🔐

A new kind of lock-picker

A quantum computer works on different physics from a normal computer. For most jobs it is not better. For the one maths problem RSA and ECC are built on, it will be dramatically better — a powerful enough machine will be able to pick today's locks.

📦

Harvest now, decrypt later

Attackers are already copying encrypted data and storing it. They cannot open it today; they plan to open it the day a capable quantum computer exists. Data that must stay trustworthy for decades — batch records, trial data, trade secrets — is at risk now if it is being harvested today.

🗓️

A published timetable

Under NIST's published transition timetable (IR 8547, draft), RSA/ECC at today's common security levels are deprecated after 2030 and disallowed after 2035. The replacement locks — post-quantum cryptography — already exist. The bottleneck is knowing where your old locks are.

1 of 24

In October 2026, the GAO reported that only 1 of the 24 major federal (CFO Act) agencies had fully addressed all of the activities for developing a prioritized inventory of its systems with vulnerable cryptography — and none had fully identified the funding needed to transition its priority systems to post-quantum cryptography.

Oct 22, 2026

OMB Memorandum M-26-15 (June 24, 2026) requires U.S. federal agencies — national security systems excluded — to submit a PQC migration plan no later than 120 days from the memorandum: October 22, 2026. Federal pressure reaches industry through supplier questionnaires.

Aug 2024

NIST published the first three finalized post-quantum cryptography standards: FIPS 203 (ML-KEM, key establishment), FIPS 204 (ML-DSA, digital signatures), and FIPS 205 (SLH-DSA, hash-based signatures). The new locks are standardized — the work is finding and replacing the old ones.

Sources: GAO-27-108740 (Oct 2026); OMB Memorandum M-26-15, “Execution of the Migration to Post-Quantum Cryptography” (June 24, 2026); NIST IR 8547 (initial public draft, Nov 2024); NIST FIPS 203/204/205 (Aug 13, 2024). Cyber insurers are also beginning to explore cryptographic-readiness indicators (CyberCube, Cyber Predictions 2026) — readiness is becoming an underwriting conversation, even though it is not yet a pricing factor.

Why pharma first

Pharma has to start earlier than everyone else

GxP systems — e-signature platforms, LIMS (laboratory information management), MES (manufacturing execution), and QMS (quality management) — sign, seal, and store records using exactly the algorithms on the NIST timetable. They are not peripheral IT; they are the systems whose records prove a drug was made correctly.

Part 11 records must stay believable for decades

Under 21 CFR Part 11, a signature made today must still be verifiable and trustworthy for the life of the product and beyond. A normal company worries about a few years of secrecy. Pharma worries about decades of provability — exactly what “harvest now, decrypt later” punishes most.

Changing the lock is regulated work

A validated system is formally tested and documented to prove it does what it claims. Swap the cryptography inside it and you disturb the validated state — triggering impact assessment, testing, documentation, and QA sign-off. IT cannot just “upgrade the encryption” over a weekend; every change needs a compliance plan around it.

Longer timelines mean an earlier start

Because each change carries revalidation, pharma's migration takes longer than generic IT's. The companies that begin with a proper inventory will do it calmly. The rest will do it in a panic, at panic prices.

What we do

Inventory, judgement, roadmap

No quantum hardware. No cryptography research. The work is structured investigation, judgement, and documentation — compliance work, wearing a new hat.

Step 1

Find

We walk your systems — on paper and in interviews — and list where RSA/ECC encryption and digital signatures are used. That list is the GxP crypto inventory.

Step 2

Judge

Each item is scored: how long must this data stay trustworthy? How exposed is it? What breaks if this lock fails? Part 11 records are scored first.

Step 3

Plan

Replacements are sequenced against the after-2030 and after-2035 timetable, in an order you can actually afford and execute — including the revalidation each change will trigger.

Step 4

Hand over

You get a board-ready report your leadership, auditors, and insurers can read without a physics degree — delivered in a fixed-scope engagement of 3–4 weeks.

Work with us

A ladder, from free to fixed-scope

Each step builds on the last. All prices are estimates, to be tested against the market — not fixed fees.

Start here
Free

Flagship report

“Your 2035 Problem: Quantum Risk in Validated Systems” — the deadline, the Part 11 problem, and the revalidation trap, in plain English. Swapped for an email address.

Do it yourself, with tools
$99–499 est.

Template pack

The GxP crypto-inventory workbook plus a vendor PQC questionnaire — the starter tools a QA team needs to begin its own inventory and ask its software vendors the right questions.

The core engagement
$15K–50K est.

PQC Readiness Assessment

A 3–4 week, fixed-scope engagement: GxP crypto inventory, data-longevity risk scoring, validated-state impact analysis, and a migration roadmap sequenced to the NIST timetable. Deliverable: a board-ready report.

Later, after an assessment
$3–5K/mo est.

Oversight retainer

Ongoing implementation oversight as you execute the roadmap, plus an annual re-assessment. Offered only after a successful assessment — never sold cold.

Why us

Built on pharma QA judgement — not cryptography hype

“Generic vendors can replace your algorithms. They cannot tell your QA director what that does to your validated state. We can.”

Quantum-Ready GxP is led by a practitioner with 14+ years in pharmaceutical QA and compliance — the inventory, risk judgement, and roadmap work is the same governance discipline applied to a new problem. The generic PQC firms sell enterprise IT migration; this practice exists for the GxP-specific questions they do not ask: Part 11 record longevity, validated-state impact, and QA-led inventory.

Honest answers

FAQ

Are you cryptographers?

No — and we will never pretend otherwise. We do not design algorithms or certify their maths. The scope is governance, inventory, risk judgement, and roadmap. The hands-on technical replacement of cryptography is partnered out or referred to a specialist firm, and we tell clients that plainly. In regulated pharma, that honesty is a selling point.

Has the FDA mandated post-quantum cryptography for GxP systems?

No. As of October 2026, the FDA has not mandated PQC for GxP. The timetable comes from NIST, and the current deadlines bind U.S. federal agencies first (OMB M-26-15). Pharma demand today is driven by foresight, federal-customer and supplier questionnaires, and insurer questions — real, but early. We would rather tell you that than sell you a mandate that does not exist.

When will quantum computers actually break RSA and ECC?

Nobody can give you an honest date, and we won't invent one. What is published is the transition timetable: under NIST IR 8547 (draft), RSA/ECC at today's common security levels are deprecated after 2030 and disallowed after 2035. And because of “harvest now, decrypt later,” long-lived records are at risk from copying today — long before any machine arrives.

We are a small company. Is this really for us?

That is exactly who this is for: small and mid-size pharma, CDMOs, and biotechs — big enough to run validated systems, small enough not to have a dedicated cryptography team. If you already have an in-house crypto programme, you do not need us.

What do we get first?

Start with the free report. If you want to begin yourselves, the template pack gives your QA team the inventory workbook and vendor questionnaire. The assessment is the step where we do the inventory, scoring, and roadmap with you and hand over a board-ready report in 3–4 weeks.

Start with the inventory

Get the free report

Your 2035 Problem: Quantum Risk in Validated Systems — the deadline, the Part 11 problem, the revalidation trap, and the five things to do Monday morning. Free, in exchange for an email address.

The download starts right away. No spam, no list resale; unsubscribe any time.